Ozempic, Wegovy and Mounjaro face US lawsuits over rare vision-loss risk

by

in

Dozens of people in the United States have sued the manufacturers of popular GLP-1 drugs, claiming that the medicines caused a rare eye condition that can result in permanent vision loss, according to US media reports.

Leave a Reply

Your email address will not be published. Required fields are marked *